Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021

SELL
$67.06 - $75.82 $1.21 Million - $1.36 Million
-17,975 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$63.89 - $73.8 $277,921 - $321,030
-4,350 Reduced 19.48%
17,975 $1.26 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $1.75 Million - $1.93 Million
-27,550 Reduced 55.24%
22,325 $1.55 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $280,992 - $326,112
-4,800 Reduced 8.78%
49,875 $3.27 Million
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $385,168 - $450,058
-7,725 Reduced 12.38%
54,675 $3.17 Million
Q3 2018

Nov 13, 2018

SELL
$46.76 - $51.24 $516,698 - $566,202
-11,050 Reduced 15.04%
62,400 $2.94 Million
Q1 2018

May 14, 2018

SELL
$48.49 - $58.14 $176,988 - $212,211
-3,650 Reduced 4.73%
73,450 $3.62 Million
Q2 2017

Aug 15, 2017

BUY
N/A
77,100
77,100 $3.31 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Kemper Corp Master Retirement Trust Portfolio

Follow Kemper Corp Master Retirement Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kemper Corp Master Retirement Trust, based on Form 13F filings with the SEC.

News

Stay updated on Kemper Corp Master Retirement Trust with notifications on news.